Pestalozzi advises the bank consortium in the USD 33.75 billion bank facilities in connection with Teva's acquisition of Allergan’s generics business (Actavis Generics)
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Allergan plc (NYSE: AGN) announced on 2 August 2016, that Teva has completed its acquisition of Allergan’s generics business. Pestalozzi advised the banking consortium, including Bank of America Merrill Lynch International Limited, Barclays Bank PLC, BNP Paribas, Citibank N.A., Credit Suisse Securities (USA) LLC, HSBC Bank Plc, Mizuho Bank, Ltd., Morgan Stanley Senior Funding, Inc., RBC Capital Markets, Sumitono Mitsui, on all Swiss legal and tax matters related to the acquisition financing for Teva Pharmaceuticals.